These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 31615932)

  • 1. Mogamulizumab Forecast: Clearer Patients, with a Slight Chance of Immune Mayhem.
    Larocca C; Kupper TS; LeBoeuf NR
    Clin Cancer Res; 2019 Dec; 25(24):7272-7274. PubMed ID: 31615932
    [TBL] [Abstract][Full Text] [Related]  

  • 2. On the Way to Curing Advanced-Stage Mycosis Fungoides/Sézary Syndrome.
    Purnak S; Hosing C; Dabaja B; Bassett RL; Huen A; Duvic M
    Clin Lymphoma Myeloma Leuk; 2024 Dec; 24(12):827-836. PubMed ID: 39107202
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radiotherapy Eradicates Malignant T Cells and Is Associated with Improved Survival in Early-Stage Mycosis Fungoides.
    O'Malley JT; de Masson A; Lowry EL; Giobbie-Hurder A; LeBoeuf NR; Larocca C; Gehad A; Seger E; Teague JE; Fisher DC; Kupper TS; Devlin PM; Clark RA
    Clin Cancer Res; 2020 Jan; 26(2):408-418. PubMed ID: 31636100
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Racial Disparities in Mycosis Fungoides/Sézary Syndrome-A Single-Center Observational Study of 292 Patients.
    Gandham AR; Geller S; Dusza SW; Kupper TS; Myskowski PL
    Clin Lymphoma Myeloma Leuk; 2024 Apr; 24(4):e174-e180. PubMed ID: 38245472
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune cell topography predicts response to PD-1 blockade in cutaneous T cell lymphoma.
    Phillips D; Matusiak M; Gutierrez BR; Bhate SS; Barlow GL; Jiang S; Demeter J; Smythe KS; Pierce RH; Fling SP; Ramchurren N; Cheever MA; Goltsev Y; West RB; Khodadoust MS; Kim YH; Schürch CM; Nolan GP
    Nat Commun; 2021 Nov; 12(1):6726. PubMed ID: 34795254
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Allogeneic Hematopoietic Cell Transplant For Bone Marrow Failure or Myelodysplastic Syndrome in Dyskeratosis Congenita/Telomere Biology Disorders: Single-Center, Single-Arm, Open-Label Trial of Reduced-Intensity Conditioning Without Radiation.
    Dimitrov M; Merkle S; Cao Q; Tryon RK; Vercellotti GM; Holtan SG; Kao RL; Srikanthan M; Terezakis SA; Tolar J; Ebens CL
    Transplant Cell Ther; 2024 Oct; 30(10):1005.e1-1005.e17. PubMed ID: 39002862
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety and activity of CTX130, a CD70-targeted allogeneic CRISPR-Cas9-engineered CAR T-cell therapy, in patients with relapsed or refractory T-cell malignancies (COBALT-LYM): a single-arm, open-label, phase 1, dose-escalation study.
    Iyer SP; Sica RA; Ho PJ; Prica A; Zain J; Foss FM; Hu B; Beitinjaneh A; Weng WK; Kim YH; Khodadoust MS; Huen AO; Williams LM; Ma A; Huang E; Ganpule A; Nagar SD; Sripakdeevong P; Cullingford EL; Karnik S; Dequeant ML; Patel JN; He XS; Li Z; He QA; Mendonez JH; Keegan A; Horwitz SM
    Lancet Oncol; 2024 Nov; ():. PubMed ID: 39617017
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Axicabtagene Ciloleucel versus Tisagenlecleucel for Relapsed or Refractory Large B Cell Lymphoma: A Systematic Review and Meta-Analysis.
    Gagelmann N; Bishop M; Ayuk F; Bethge W; Glass B; Sureda A; Pasquini MC; Kröger N
    Transplant Cell Ther; 2024 Jun; 30(6):584.e1-584.e13. PubMed ID: 38281590
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemotherapy alone versus chemotherapy plus radiotherapy for adults with early-stage Hodgkin's lymphoma.
    Goldkuhle M; Kreuzberger N; von Tresckow B; Eichenauer DA; Specht L; Monsef I; Skoetz N
    Cochrane Database Syst Rev; 2024 Dec; 12(12):CD007110. PubMed ID: 39620432
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antioxidants for female subfertility.
    Showell MG; Mackenzie-Proctor R; Jordan V; Hart RJ
    Cochrane Database Syst Rev; 2020 Aug; 8(8):CD007807. PubMed ID: 32851663
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neoadjuvant and adjuvant toripalimab for locoregionally advanced nasopharyngeal carcinoma: a randomised, single-centre, double-blind, placebo-controlled, phase 2 trial.
    Liu SL; Li XY; Yang JH; Wen DX; Guo SS; Liu LT; Li YF; Luo MJ; Xie SY; Liang YJ; Sun XS; Yang ZC; Lv XF; Luo DH; Li JB; Liu Q; Wang P; Guo L; Mo HY; Sun R; Yang Q; Lan KQ; Jia GD; Li R; Zhao C; Xu RH; Chen QY; Tang LQ; Mai HQ
    Lancet Oncol; 2024 Dec; 25(12):1563-1575. PubMed ID: 39522541
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Galcanezumab add-on in refractory cluster headache. A case series.
    Karagiorgis G; Christofilos S; Deligianni C; Spanou I; Vassilopoulou S; Mitsikostas DD
    Pain Manag; 2024 Sep; 14(9):491-495. PubMed ID: 39558673
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of Two Modern Survival Prediction Tools, SORG-MLA and METSSS, in Patients With Symptomatic Long-bone Metastases Who Underwent Local Treatment With Surgery Followed by Radiotherapy and With Radiotherapy Alone.
    Lee CC; Chen CW; Yen HK; Lin YP; Lai CY; Wang JL; Groot OQ; Janssen SJ; Schwab JH; Hsu FM; Lin WH
    Clin Orthop Relat Res; 2024 Dec; 482(12):2193-2208. PubMed ID: 39051924
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and Safety of a Therapy Combining Sintilimab and Chemotherapy With Cryoablation in the First-Line Treatment of Advanced Nonsquamous Non-Small Cell Lung Cancer: Protocol for a Phase II, Pilot, Single-Arm, Single-Center Study.
    Gao Z; Teng J; Qiao R; Qian J; Pan F; Ma M; Lu J; Zhang B; Chu T; Zhong H
    JMIR Res Protoc; 2024 Nov; 13():e64950. PubMed ID: 39514267
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Medications for chronic obstructive pulmonary disease: a historical non-interventional cohort study with validation against RCT results.
    Wing K; Williamson E; Carpenter JR; Wise L; Schneeweiss S; Smeeth L; Quint JK; Douglas I
    Health Technol Assess; 2021 Aug; 25(51):1-70. PubMed ID: 34463610
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Valemetostat for patients with relapsed or refractory peripheral T-cell lymphoma (VALENTINE-PTCL01): a multicentre, open-label, single-arm, phase 2 study.
    Zinzani PL; Izutsu K; Mehta-Shah N; Barta SK; Ishitsuka K; Córdoba R; Kusumoto S; Bachy E; Cwynarski K; Gritti G; Prica A; Jacobsen E; Feldman T; Guillermin Y; Ennishi D; Yoon DH; Domenech ED; Zain J; Wang J; Kim JS; Poel MV; Jin J; Wu S; Chen Y; Moriyama T; Inoue A; Nakajima K; Horwitz SM
    Lancet Oncol; 2024 Dec; 25(12):1602-1613. PubMed ID: 39486433
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lamotrigine versus levetiracetam or zonisamide for focal epilepsy and valproate versus levetiracetam for generalised and unclassified epilepsy: two SANAD II non-inferiority RCTs.
    Marson AG; Burnside G; Appleton R; Smith D; Leach JP; Sills G; Tudur-Smith C; Plumpton CO; Hughes DA; Williamson PR; Baker G; Balabanova S; Taylor C; Brown R; Hindley D; Howell S; Maguire M; Mohanraj R; Smith PE
    Health Technol Assess; 2021 Dec; 25(75):1-134. PubMed ID: 34931602
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Matching-adjusted indirect comparison of acalabrutinib versus ibrutinib in relapsed/refractory mantle cell lymphoma.
    Cai L; Roos J; Miranda PAP; Liljas B; Rule S; Wang M
    J Med Econ; 2024; 27(1):1552-1557. PubMed ID: 39461001
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of prostate radiotherapy in de novo metastatic castration-sensitive prostate cancer (PEACE-1): a multicentre, open-label, randomised, phase 3 study with a 2 × 2 factorial design.
    Bossi A; Foulon S; Maldonado X; Sargos P; MacDermott R; Kelly P; Fléchon A; Tombal B; Supiot S; Berthold D; Ronchin P; Kacso G; Salem N; Calabro F; Berdah JF; Hasbini A; Silva M; Boustani J; Ribault H; Fizazi K;
    Lancet; 2024 Nov; 404(10467):2065-2076. PubMed ID: 39580202
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.